TABLE 1

Sexually-transmitted infection phenotype determined by transcription-mediated amplification specific for Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis within screened males who were positive for at least one STIa

STI phenotypeb,cNo. (%) of patients delineated by healthcare setting
M. genitaliumC. trachomatisN. gonorrhoeaeT. vaginalisSTI clinicCommunity careP value
+97d (36.5)e46 (22.0)0.0007
++17 (6.4)10 (4.8)0.45
++9 (3.4)2 (1.0)0.08
+69 (25.9)67 (32.1)0.14
++10 (3.8)13 (6.2)0.22
+44 (16.5)26 (12.4)0.21
+14 (5.3)39 (18.7)<0.0002
Any M. genitalium detection126 (47.4)62 (29.7)0.0002
Any C. trachomatis detection97 (36.5)92 (44.0)0.10
Any N. gonorrhoeae detection68 (25.6)43 (20.6)0.20
Any T. vaginalis detection19 (7.1)44 (21.1)<0.0002
  • a Adapted from reference 28 with permission from Elsevier.

  • b +, positive transcription-mediated amplification screen; −, negative transcription-mediated amplification screen.

  • c Phenotypes that were observed in <1.5% of patients at both the STI clinic and community care are not included in this table. No significant difference was noted within each of these comparisons.

  • d This value indicates the number of phenotypes.

  • e This value indicates the percentage of phenotypes per clinic distribution.